已收盘 03-27 16:00:00 美东时间
-0.270
-0.11%
今日重点评级关注:Guggenheim:维持Cabaletta Bio"买入"评级,目标价从15美元升至16美元;HC Wainwright & Co.:维持Palvella Therapeutics"买入"评级,目标价从255美元升至270美元
03-25 10:31
Shares of oil and gas companies are trading higher as the commodity resumes its...
03-24 23:31
今日重点评级关注:RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从32美元升至35美元;巴克莱:维持CytomX医疗"超配"评级,目标价从10美元升至16美元
03-20 15:53
今日重点评级关注:Piper Sandler:维持Allogene疗法"超配"评级,目标价从7美元升至8美元;B. Riley证券:维持Oncology Institute"买入"评级,目标价从6美元升至8美元
03-16 18:19
Wells Fargo analyst Michael Blum maintains Targa Resources (NYSE:TRGP) with a Overweight and raises the price target from $248 to $264.
03-13 22:39
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22
今日重点评级关注:巴克莱:维持C4 Therapeutics"超配"评级,目标价从5美元升至7美元;富国银行:维持Agilon Health"超配"评级,目标价从1美元升至1.5美元
03-02 14:08
RBC Capital analyst Elvira Scotto maintains Targa Resources (NYSE:TRGP) with a Outperform and raises the price target from $218 to $260.
02-28 02:05
An update from Targa Resources ( ($TRGP) ) is now available. On February 25, 20...
02-27 05:45
Targa Resources Corp. announced the pricing of an underwritten public offering of $750 million aggregate principal amount of its 4.350% Senior Notes due 2031 and $750 million of its 6.050% Senior Notes due 2056. The Offering is expected to close on March 2, 2026. Proceeds will be used for general corporate purposes, including repaying debt, repurchasing securities, and funding capital expenditures. The Offering is being made under an effective sh...
02-25 23:16